Coloplast Corporation is facing a new Atlis sling lawsuit, alleging the transvaginal mesh device caused serious injuries to the claimant. The Atlis sling lawsuit was recently filed by a woman who had the device implanted for typical treatment purposes but reportedly suffered complications soon after implantation.

Plaintiff Tina G. filed the Altis sling lawsuit soon after discovering other women had complained of similar injuries. Coloplast is one of several companies facing litigation action for allegedly defective transvaginal mesh products.

Like other transvaginal mesh products, the Altis sling is often recommended to women suffering from either pelvic organ prolapse (POP) or stress urinary incontinence (SUI). These health conditions are caused by weakening pelvic muscles, which may have been damaged by disease or physically traumatic events like childbirth.

Transvaginal mesh provides an extra support lining to help strength the pelvic muscle, which prevents organ prolapse and uncontrolled urination. The Altis sling and other transvaginal mesh products are supposed to provide a discrete treatment method for these personal health problems, but have allegedly been posing serious health risks.

This was also allegedly the case with Tina, who says she had the Altis sling implanted for SUI treatment on Dec. 2, 2016. While Tina reportedly had no initial complications, the Altis sling lawsuit alleges she suffered serious health complications not long after.

According to the Altis sling lawsuit, Tina suffered symptoms of foreign body reaction, mesh erosion, stress incontinence, and vaginal bleeding. Tina says she has since been forced to contend with the long lasting effects of these injuries, which consequently gave her a diminished quality of life.

Tina argues the company either knew or should have known that their device was potentially defective.

Overview of Transvaginal Mesh Complications

Over 100,000 transvaginal mesh lawsuits have been filed across the United States and has become one of the largest mass torts in the history of the country. Coloplast and other companies have already paid billions in transvaginal mesh settlement funds, which are paid out to victims like Tina who suffered serious transvaginal mesh complications.

While surgical mesh has been used for gynecological purposes for decades, the FDA and other health officials started reviewing the health impacts these devices could be having on women. The FDA recently issued a classification change of POP transvaginal mesh products in 2016 as high risk devices, when they were previously moderate risk.

While the label change did not apply to SUI transvaginal mesh products, they should still be treated with caution. The trasnvaginal mesh complications often reported include, but are not limited to:

• Painful Sexual Intercourse
• Urination Problems
• Multiple Occurrences of Pelvic Organ Prolapse
• Vaginal Scarring
• Mesh Erosion into the Vagina
• Infection
• Organ Damage

Even though these transvaginal mesh complications can be devastating to women, Coloplast and other manufacturers are accused of failing to warn the general public.

At all times relevant, Tina claims, she and her physician had relied on the product information provided by Coloplast and had no reason to be wary of any serious device complications. Tina states she would not have agreed to have the Altis sling implanted, if she knew the risk of transvaginal mesh complications.

This Transvaginal Mesh Lawsuit is Case No. N18C-08-057 PEL, in the Superior Court of the state of Delaware.